Bio-Rad Introduces StarBright Blue and StarBright Yellow Dyes to Enhance Multiplex Flow Cytometry

StarBright Blue and StarBright Yellow Dyes Conjugated to Highly Validated Antibodies for Conventional and Full Spectrum Flow Cytometry in Immunology Research HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of both the StarBright™ Blue-series and StarBright™ Yellow-series Dyes [...]

SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development

The expanded partnership aims to leverage the global SOPHiA DDM™ platform and multimodal algorithmic capabilities to lead a new era of precision oncology by improving early patient identification and diagnosis, optimizing clinical development, and accelerating adoption of innovative medications along the care pathway BOSTON & LAUSANNE, Switzerland -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator [...]

Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein

HCP-ELISA builds upon Company’s HCP-GAPex℠ service, increasing the efficiency and efficacy of HCP assay development WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit for the detection and quantitation of residual host cell proteins (HCP) in CHO-based biotherapeutics. Charles River’s HCP ELISA kit achieves [...]

Molecular Devices inks deal with HUB Organoids to advance automated intestinal organoid screening technology

SAN JOSE, Calif., and UTRECHT, Netherlands – Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HUB Organoids (HUB), the pioneer in the field of adult stem cell-derived organoids, today announced a strategic collaboration enabling continued development of next-generation 3D biology technologies that drive step-change reduction in pre-clinical to clinical drug attrition. Under terms [...]

Next Generation of Innovators Step Up to Tackle World’s Biggest Water Challenges

Start-ups Join Xylem Innovation Labs Accelerator to Scale Breakthrough Technologies to Solve Critical Water Issues WASHINGTON -- Global water technology company Xylem (NYSE: XYL) is supporting emerging technology companies and accelerating the development of breakthrough solutions through its Xylem Innovation Labs commercial accelerator program. Now in its second year, the program has just accepted 10 new startups [...]

Automata partners with The Francis Crick Institute on integrated automation for genomics

Integrated automation will support the Crick’s cutting-edge advanced genomics laboratory with greater walkaway time, R&D flexibility and data quality than ever before. London UK – Automata, a leading automation company powering life sciences labs, today announced it is partnering with the Advanced Sequencing Facility (ASF) at The Francis Crick Institute, a world-leading laboratory at the forefront [...]

Waters Corporation Introduces New Test Protocol and a New Addition to Certified Sample Vial Portfolio

Certified contaminant-free LC/GC and LC/MS sample vials reduce risk of contamination and help ensure top-quality and reproducible test results WHO: Waters Corporation, Milford, Massachusetts, USA WHAT: Waters Corp announces a new test protocol for its Waters LC/GC Certified Vials along with a new addition to its line of Waters TruView pH Control LC/MS Certified Vials. The Waters LC/GC Certified [...]

Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

NovoExpress enables regulatory compliance for pharmaceutical and biopharmaceutical manufacturing SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the release of new NovoExpress software that introduces integrated compliance tools for NovoCyte flow cytometer systems. The compliance-enabling features enable users to meet regulatory requirements defined in FDA 21 CFR Part 11 and Annex 11. There is immense pressure on [...]

CytoRecovery Awarded National Science Foundation Phase II SBIR Research Grant

Provides funding of $952,000 to advance the Company’s revolutionary CytoR1 platform for the rapid sorting and recovery of live cells. BLACKSBURG, Virginia USA – CytoRecovery, Inc., a leader in marker free technologies for the enrichment, sorting, and recovery of live cells, announced today that the National Science Foundation (NSF) has approved its application to receive a Phase [...]

Repligen Appoints Martin D. Madaus to Board of Directors

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences tools industry leader Martin D. Madaus. Dr. Madaus brings to the Repligen board over 25 years of industry experience, including five years as Chairman, President and Chief Executive Officer of Millipore Corporation, where he was integral to [...]

Access IBO on Knowledge Center